nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—CYP3A4—Temozolomide—malignant glioma	0.238	1	CbGbCtD
Chenodeoxycholic acid—NR1H4—skull—malignant glioma	0.0683	0.434	CbGeAlD
Chenodeoxycholic acid—CYP27A1—vertebral column—malignant glioma	0.0501	0.318	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—POR—malignant glioma	0.0184	0.0877	CbGpPWpGaD
Chenodeoxycholic acid—Pulmonary fibrosis—Carmustine—malignant glioma	0.00898	0.0227	CcSEcCtD
Chenodeoxycholic acid—Pulmonary fibrosis—Temozolomide—malignant glioma	0.00868	0.022	CcSEcCtD
Chenodeoxycholic acid—Lung infiltration—Carmustine—malignant glioma	0.00842	0.0213	CcSEcCtD
Chenodeoxycholic acid—Interstitial pneumonia—Temozolomide—malignant glioma	0.0079	0.02	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—medulla oblongata—malignant glioma	0.00784	0.0498	CbGeAlD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00746	0.0356	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—midbrain—malignant glioma	0.00717	0.0455	CbGeAlD
Chenodeoxycholic acid—CYP27A1—spinal cord—malignant glioma	0.00699	0.0444	CbGeAlD
Chenodeoxycholic acid—Transaminases increased—Carmustine—malignant glioma	0.00649	0.0164	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00648	0.0309	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.00639	0.0305	CbGpPWpGaD
Chenodeoxycholic acid—Cyst—Carmustine—malignant glioma	0.00591	0.015	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—central nervous system—malignant glioma	0.00567	0.036	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00562	0.0268	CbGpPWpGaD
Chenodeoxycholic acid—Interstitial lung disease—Carmustine—malignant glioma	0.00558	0.0141	CcSEcCtD
Chenodeoxycholic acid—Thrombosis—Carmustine—malignant glioma	0.00558	0.0141	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—cerebellum—malignant glioma	0.00555	0.0352	CbGeAlD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00554	0.0265	CbGpPWpGaD
Chenodeoxycholic acid—Interstitial lung disease—Temozolomide—malignant glioma	0.00539	0.0137	CcSEcCtD
Chenodeoxycholic acid—Lung disorder—Temozolomide—malignant glioma	0.00539	0.0137	CcSEcCtD
Chenodeoxycholic acid—Influenza-like symptoms—Temozolomide—malignant glioma	0.00534	0.0135	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00525	0.0251	CbGpPWpGaD
Chenodeoxycholic acid—Menorrhagia—Temozolomide—malignant glioma	0.00516	0.0131	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Orphan transporters—COX8A—malignant glioma	0.00503	0.024	CbGpPWpGaD
Chenodeoxycholic acid—Cholestasis—Temozolomide—malignant glioma	0.00503	0.0127	CcSEcCtD
Chenodeoxycholic acid—Otitis media—Temozolomide—malignant glioma	0.0049	0.0124	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00474	0.0226	CbGpPWpGaD
Chenodeoxycholic acid—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00464	0.0118	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00455	0.0217	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—brain—malignant glioma	0.0045	0.0286	CbGeAlD
Chenodeoxycholic acid—Accidental injury—Carmustine—malignant glioma	0.00446	0.0113	CcSEcCtD
Chenodeoxycholic acid—Drug interaction—Carmustine—malignant glioma	0.00426	0.0108	CcSEcCtD
Chenodeoxycholic acid—Viral infection—Temozolomide—malignant glioma	0.00423	0.0107	CcSEcCtD
Chenodeoxycholic acid—Herpes simplex—Temozolomide—malignant glioma	0.00414	0.0105	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00411	0.0196	CbGpPWpGaD
Chenodeoxycholic acid—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00404	0.0102	CcSEcCtD
Chenodeoxycholic acid—Neck pain—Carmustine—malignant glioma	0.004	0.0101	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Orphan transporters—APOD—malignant glioma	0.00391	0.0187	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal pain—Temozolomide—malignant glioma	0.00386	0.00979	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00384	0.0183	CbGpPWpGaD
Chenodeoxycholic acid—Vaginal inflammation—Temozolomide—malignant glioma	0.00382	0.00967	CcSEcCtD
Chenodeoxycholic acid—Urinary incontinence—Carmustine—malignant glioma	0.00381	0.00966	CcSEcCtD
Chenodeoxycholic acid—Influenza like illness—Temozolomide—malignant glioma	0.00371	0.00939	CcSEcCtD
Chenodeoxycholic acid—Urinary incontinence—Temozolomide—malignant glioma	0.00369	0.00934	CcSEcCtD
Chenodeoxycholic acid—Vaginal infection—Temozolomide—malignant glioma	0.0036	0.00913	CcSEcCtD
Chenodeoxycholic acid—Neoplasm—Carmustine—malignant glioma	0.00357	0.00905	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00345	0.0165	CbGpPWpGaD
Chenodeoxycholic acid—Neoplasm—Temozolomide—malignant glioma	0.00345	0.00874	CcSEcCtD
Chenodeoxycholic acid—Abnormal vision—Carmustine—malignant glioma	0.00345	0.00873	CcSEcCtD
Chenodeoxycholic acid—Abnormal vision—Temozolomide—malignant glioma	0.00333	0.00843	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00333	0.0159	CbGpPWpGaD
Chenodeoxycholic acid—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00319	0.00807	CcSEcCtD
Chenodeoxycholic acid—Injury—Carmustine—malignant glioma	0.00312	0.0079	CcSEcCtD
Chenodeoxycholic acid—Deafness—Temozolomide—malignant glioma	0.0031	0.00785	CcSEcCtD
Chenodeoxycholic acid—Amnesia—Carmustine—malignant glioma	0.00305	0.00773	CcSEcCtD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—PPARG—malignant glioma	0.00296	0.0141	CbGpPWpGaD
Chenodeoxycholic acid—Amnesia—Temozolomide—malignant glioma	0.00295	0.00747	CcSEcCtD
Chenodeoxycholic acid—Diplopia—Carmustine—malignant glioma	0.00287	0.00726	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00287	0.00726	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00284	0.0136	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP2B6—malignant glioma	0.00279	0.0133	CbGpPWpGaD
Chenodeoxycholic acid—Diplopia—Temozolomide—malignant glioma	0.00277	0.00702	CcSEcCtD
Chenodeoxycholic acid—Face oedema—Carmustine—malignant glioma	0.00277	0.00701	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP2B6—malignant glioma	0.00275	0.0131	CbGpPWpGaD
Chenodeoxycholic acid—Face oedema—Temozolomide—malignant glioma	0.00268	0.00678	CcSEcCtD
Chenodeoxycholic acid—Liver function test abnormal—Carmustine—malignant glioma	0.00265	0.0067	CcSEcCtD
Chenodeoxycholic acid—Dehydration—Temozolomide—malignant glioma	0.00258	0.00653	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00252	0.012	CbGpPWpGaD
Chenodeoxycholic acid—Breast disorder—Temozolomide—malignant glioma	0.0025	0.00634	CcSEcCtD
Chenodeoxycholic acid—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0025	0.00632	CcSEcCtD
Chenodeoxycholic acid—Dysphagia—Carmustine—malignant glioma	0.00248	0.00628	CcSEcCtD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—BCL2—malignant glioma	0.00245	0.0117	CbGpPWpGaD
Chenodeoxycholic acid—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00244	0.00619	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP2C18—malignant glioma	0.00242	0.0115	CbGpPWpGaD
Chenodeoxycholic acid—Dysphagia—Temozolomide—malignant glioma	0.00239	0.00607	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00239	0.0114	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP2C18—malignant glioma	0.00239	0.0114	CbGpPWpGaD
Chenodeoxycholic acid—Bronchitis—Temozolomide—malignant glioma	0.0023	0.00583	CcSEcCtD
Chenodeoxycholic acid—Dysuria—Temozolomide—malignant glioma	0.00224	0.00567	CcSEcCtD
Chenodeoxycholic acid—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00223	0.00564	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Carmustine—malignant glioma	0.00222	0.00563	CcSEcCtD
Chenodeoxycholic acid—Pollakiuria—Temozolomide—malignant glioma	0.00221	0.0056	CcSEcCtD
Chenodeoxycholic acid—Depression—Carmustine—malignant glioma	0.0022	0.00558	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—FTH1—malignant glioma	0.00219	0.0104	CbGpPWpGaD
Chenodeoxycholic acid—Photosensitivity reaction—Temozolomide—malignant glioma	0.00219	0.00554	CcSEcCtD
Chenodeoxycholic acid—Weight increased—Temozolomide—malignant glioma	0.00218	0.00552	CcSEcCtD
Chenodeoxycholic acid—Renal failure—Carmustine—malignant glioma	0.00217	0.0055	CcSEcCtD
Chenodeoxycholic acid—Weight decreased—Temozolomide—malignant glioma	0.00217	0.00549	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Carmustine—malignant glioma	0.00215	0.00544	CcSEcCtD
Chenodeoxycholic acid—Pneumonia—Temozolomide—malignant glioma	0.00215	0.00544	CcSEcCtD
Chenodeoxycholic acid—Infestation NOS—Temozolomide—malignant glioma	0.00214	0.00541	CcSEcCtD
Chenodeoxycholic acid—Infestation—Temozolomide—malignant glioma	0.00214	0.00541	CcSEcCtD
Chenodeoxycholic acid—Depression—Temozolomide—malignant glioma	0.00213	0.00539	CcSEcCtD
Chenodeoxycholic acid—Urinary tract infection—Temozolomide—malignant glioma	0.00208	0.00526	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP2B6—malignant glioma	0.00204	0.00973	CbGpPWpGaD
Chenodeoxycholic acid—Hepatobiliary disease—Temozolomide—malignant glioma	0.00202	0.00511	CcSEcCtD
Chenodeoxycholic acid—Sinusitis—Temozolomide—malignant glioma	0.002	0.00507	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Carmustine—malignant glioma	0.00199	0.00505	CcSEcCtD
Chenodeoxycholic acid—Haemorrhage—Carmustine—malignant glioma	0.00198	0.00502	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTT1—malignant glioma	0.00196	0.00934	CbGpPWpGaD
Chenodeoxycholic acid—Oedema peripheral—Carmustine—malignant glioma	0.00195	0.00495	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Carmustine—malignant glioma	0.00195	0.00494	CcSEcCtD
Chenodeoxycholic acid—Haemoglobin—Temozolomide—malignant glioma	0.00193	0.00488	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00192	0.00917	CbGpPWpGaD
Chenodeoxycholic acid—Haemorrhage—Temozolomide—malignant glioma	0.00192	0.00485	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Carmustine—malignant glioma	0.00191	0.00484	CcSEcCtD
Chenodeoxycholic acid—Pharyngitis—Temozolomide—malignant glioma	0.0019	0.00482	CcSEcCtD
Chenodeoxycholic acid—Urinary tract disorder—Temozolomide—malignant glioma	0.00189	0.00479	CcSEcCtD
Chenodeoxycholic acid—Oedema peripheral—Temozolomide—malignant glioma	0.00189	0.00478	CcSEcCtD
Chenodeoxycholic acid—Connective tissue disorder—Temozolomide—malignant glioma	0.00188	0.00477	CcSEcCtD
Chenodeoxycholic acid—Urethral disorder—Temozolomide—malignant glioma	0.00188	0.00476	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Carmustine—malignant glioma	0.00185	0.00469	CcSEcCtD
Chenodeoxycholic acid—Visual impairment—Temozolomide—malignant glioma	0.00185	0.00468	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—PTGS1—malignant glioma	0.00183	0.00875	CbGpPWpGaD
Chenodeoxycholic acid—Eye disorder—Temozolomide—malignant glioma	0.00179	0.00454	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Temozolomide—malignant glioma	0.00179	0.00453	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Temozolomide—malignant glioma	0.00178	0.00451	CcSEcCtD
Chenodeoxycholic acid—Arrhythmia—Carmustine—malignant glioma	0.00177	0.00449	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP2C18—malignant glioma	0.00177	0.00844	CbGpPWpGaD
Chenodeoxycholic acid—Alopecia—Carmustine—malignant glioma	0.00175	0.00444	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Temozolomide—malignant glioma	0.00174	0.0044	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Temozolomide—malignant glioma	0.00173	0.00439	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Temozolomide—malignant glioma	0.00173	0.00438	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Carmustine—malignant glioma	0.00173	0.00437	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.00173	0.00824	CbGpPWpGaD
Chenodeoxycholic acid—Chills—Temozolomide—malignant glioma	0.00172	0.00436	CcSEcCtD
Chenodeoxycholic acid—Alopecia—Temozolomide—malignant glioma	0.00169	0.00429	CcSEcCtD
Chenodeoxycholic acid—Back pain—Carmustine—malignant glioma	0.00167	0.00423	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Temozolomide—malignant glioma	0.00167	0.00423	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.00163	0.00779	CbGpPWpGaD
Chenodeoxycholic acid—Back pain—Temozolomide—malignant glioma	0.00161	0.00409	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Carmustine—malignant glioma	0.0016	0.00404	CcSEcCtD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—malignant glioma	0.00157	0.0075	CbGpPWpGaD
Chenodeoxycholic acid—Ill-defined disorder—Temozolomide—malignant glioma	0.00155	0.00392	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Carmustine—malignant glioma	0.00155	0.00391	CcSEcCtD
Chenodeoxycholic acid—Anaemia—Temozolomide—malignant glioma	0.00154	0.00391	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Temozolomide—malignant glioma	0.00152	0.00386	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTT1—malignant glioma	0.00152	0.00727	CbGpPWpGaD
Chenodeoxycholic acid—Malaise—Temozolomide—malignant glioma	0.0015	0.00381	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Temozolomide—malignant glioma	0.0015	0.0038	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Carmustine—malignant glioma	0.0015	0.00379	CcSEcCtD
Chenodeoxycholic acid—Leukopenia—Temozolomide—malignant glioma	0.00149	0.00378	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Carmustine—malignant glioma	0.00149	0.00378	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Temozolomide—malignant glioma	0.00147	0.00373	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Carmustine—malignant glioma	0.00147	0.00372	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Carmustine—malignant glioma	0.00147	0.00372	CcSEcCtD
Chenodeoxycholic acid—Cough—Temozolomide—malignant glioma	0.00146	0.00369	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Temozolomide—malignant glioma	0.00145	0.00366	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Temozolomide—malignant glioma	0.00144	0.00365	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTT1—malignant glioma	0.00143	0.00682	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Carmustine—malignant glioma	0.00142	0.0036	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Temozolomide—malignant glioma	0.00142	0.0036	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Temozolomide—malignant glioma	0.00142	0.0036	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.00142	0.00675	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00141	0.00357	CcSEcCtD
Chenodeoxycholic acid—Oedema—Carmustine—malignant glioma	0.00141	0.00357	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Temozolomide—malignant glioma	0.0014	0.00355	CcSEcCtD
Chenodeoxycholic acid—Infection—Carmustine—malignant glioma	0.0014	0.00355	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Temozolomide—malignant glioma	0.00139	0.00352	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Carmustine—malignant glioma	0.00138	0.00349	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Carmustine—malignant glioma	0.00138	0.00348	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Temozolomide—malignant glioma	0.00137	0.00348	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—RTEL1—malignant glioma	0.00137	0.00654	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—central nervous system—malignant glioma	0.00137	0.00869	CbGeAlD
Chenodeoxycholic acid—Oedema—Temozolomide—malignant glioma	0.00136	0.00345	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—GSTP1—malignant glioma	0.00136	0.00647	CbGpPWpGaD
Chenodeoxycholic acid—Infection—Temozolomide—malignant glioma	0.00135	0.00343	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Carmustine—malignant glioma	0.00134	0.0034	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Biological oxidations—PTGS1—malignant glioma	0.00134	0.00639	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—GSTP1—malignant glioma	0.00134	0.00638	CbGpPWpGaD
Chenodeoxycholic acid—Nervous system disorder—Temozolomide—malignant glioma	0.00134	0.00338	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Temozolomide—malignant glioma	0.00133	0.00338	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.00133	0.00633	CbGpPWpGaD
Chenodeoxycholic acid—Skin disorder—Temozolomide—malignant glioma	0.00132	0.00335	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Carmustine—malignant glioma	0.00132	0.00334	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Temozolomide—malignant glioma	0.00132	0.00333	CcSEcCtD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—NCOR1—malignant glioma	0.0013	0.00621	CbGpPWpGaD
Chenodeoxycholic acid—Anorexia—Temozolomide—malignant glioma	0.0013	0.00329	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00128	0.00325	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—malignant glioma	0.00127	0.00608	CbGpPWpGaD
Chenodeoxycholic acid—Insomnia—Carmustine—malignant glioma	0.00127	0.00323	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP2B6—malignant glioma	0.00127	0.00606	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Carmustine—malignant glioma	0.00127	0.00321	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Carmustine—malignant glioma	0.00126	0.00318	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP2B6—malignant glioma	0.00125	0.00598	CbGpPWpGaD
Chenodeoxycholic acid—Somnolence—Carmustine—malignant glioma	0.00125	0.00317	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00124	0.00314	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Temozolomide—malignant glioma	0.00123	0.00312	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00123	0.00586	CbGpPWpGaD
Chenodeoxycholic acid—Decreased appetite—Carmustine—malignant glioma	0.00123	0.0031	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Temozolomide—malignant glioma	0.00122	0.0031	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Carmustine—malignant glioma	0.00122	0.00308	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Temozolomide—malignant glioma	0.00121	0.00308	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Temozolomide—malignant glioma	0.00121	0.00307	CcSEcCtD
Chenodeoxycholic acid—Constipation—Carmustine—malignant glioma	0.00121	0.00305	CcSEcCtD
Chenodeoxycholic acid—Pain—Carmustine—malignant glioma	0.00121	0.00305	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Temozolomide—malignant glioma	0.0012	0.00304	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Temozolomide—malignant glioma	0.00118	0.003	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00118	0.00561	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00118	0.00298	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Temozolomide—malignant glioma	0.00117	0.00297	CcSEcCtD
Chenodeoxycholic acid—Pain—Temozolomide—malignant glioma	0.00116	0.00295	CcSEcCtD
Chenodeoxycholic acid—Constipation—Temozolomide—malignant glioma	0.00116	0.00295	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Carmustine—malignant glioma	0.00116	0.00294	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Carmustine—malignant glioma	0.00115	0.00292	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00112	0.00536	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Temozolomide—malignant glioma	0.00112	0.00284	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00112	0.00535	CbGpPWpGaD
Chenodeoxycholic acid—Abdominal pain—Carmustine—malignant glioma	0.00111	0.00282	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Carmustine—malignant glioma	0.00111	0.00282	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Temozolomide—malignant glioma	0.00111	0.00282	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP2C18—malignant glioma	0.0011	0.00526	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP2C18—malignant glioma	0.00109	0.00519	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Temozolomide—malignant glioma	0.00108	0.00274	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Temozolomide—malignant glioma	0.00108	0.00273	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Temozolomide—malignant glioma	0.00108	0.00273	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00107	0.00509	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Phase II conjugation—GSTP1—malignant glioma	0.00106	0.00504	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Carmustine—malignant glioma	0.00104	0.00263	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Carmustine—malignant glioma	0.00101	0.00256	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Temozolomide—malignant glioma	0.001	0.00254	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RTEL1—malignant glioma	0.001	0.00478	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—GSTP1—malignant glioma	0.000991	0.00473	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000982	0.00469	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00098	0.00468	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Temozolomide—malignant glioma	0.000977	0.00247	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Carmustine—malignant glioma	0.000964	0.00244	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Temozolomide—malignant glioma	0.000964	0.00244	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000956	0.00456	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000948	0.00453	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—PPARA activates gene expression—PPARG—malignant glioma	0.000933	0.00445	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Carmustine—malignant glioma	0.000932	0.00236	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Temozolomide—malignant glioma	0.000932	0.00236	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—malignant glioma	0.000913	0.00436	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Temozolomide—malignant glioma	0.000901	0.00228	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Carmustine—malignant glioma	0.000896	0.00227	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTT1—malignant glioma	0.000891	0.00425	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Carmustine—malignant glioma	0.000889	0.00225	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Carmustine—malignant glioma	0.000888	0.00225	CcSEcCtD
Chenodeoxycholic acid—Headache—Carmustine—malignant glioma	0.000883	0.00224	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—malignant glioma	0.000878	0.00419	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC5A5—malignant glioma	0.000874	0.00417	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Temozolomide—malignant glioma	0.000866	0.00219	CcSEcCtD
Chenodeoxycholic acid—Rash—Temozolomide—malignant glioma	0.000859	0.00217	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Temozolomide—malignant glioma	0.000858	0.00217	CcSEcCtD
Chenodeoxycholic acid—Headache—Temozolomide—malignant glioma	0.000853	0.00216	CcSEcCtD
Chenodeoxycholic acid—Nausea—Carmustine—malignant glioma	0.000837	0.00212	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—PTGS1—malignant glioma	0.000835	0.00399	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—SLC6A3—malignant glioma	0.000832	0.00397	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Temozolomide—malignant glioma	0.000809	0.00205	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—COX8A—malignant glioma	0.000788	0.00376	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000727	0.00347	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.00072	0.00344	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000716	0.00342	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—GSTP1—malignant glioma	0.000704	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000704	0.00336	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000693	0.00331	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000678	0.00323	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ASMT—malignant glioma	0.00067	0.0032	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000669	0.00319	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000655	0.00312	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—BCAN—malignant glioma	0.00063	0.003	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—malignant glioma	0.000629	0.003	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—RTEL1—malignant glioma	0.000625	0.00298	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—GSTP1—malignant glioma	0.000618	0.00295	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—GSTP1—malignant glioma	0.000609	0.00291	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000588	0.0028	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00058	0.00277	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—COX8A—malignant glioma	0.000576	0.00275	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH3—malignant glioma	0.000569	0.00272	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—PDGFB—malignant glioma	0.000557	0.00266	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000549	0.00262	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000515	0.00246	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH2—malignant glioma	0.00051	0.00244	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—IDH2—malignant glioma	0.000508	0.00242	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ASMT—malignant glioma	0.000489	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000489	0.00233	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000479	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000478	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2B6—malignant glioma	0.000477	0.00228	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000476	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BCAN—malignant glioma	0.00046	0.0022	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000449	0.00214	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—CDKN2B—malignant glioma	0.000439	0.00209	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—IDH1—malignant glioma	0.000436	0.00208	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000428	0.00204	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SPHK1—malignant glioma	0.000422	0.00202	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NCOR1—malignant glioma	0.000416	0.00199	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP2C18—malignant glioma	0.000414	0.00197	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000397	0.00189	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00039	0.00186	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—DNMT3B—malignant glioma	0.000389	0.00186	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—HIST1H3B—malignant glioma	0.000378	0.0018	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—IDH2—malignant glioma	0.000371	0.00177	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000361	0.00172	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—COX8A—malignant glioma	0.000359	0.00171	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000355	0.0017	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00035	0.00167	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2B6—malignant glioma	0.000349	0.00166	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000343	0.00164	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000342	0.00163	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTT1—malignant glioma	0.000335	0.0016	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—IDH1—malignant glioma	0.000319	0.00152	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—NOTCH1—malignant glioma	0.000316	0.00151	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS1—malignant glioma	0.000314	0.0015	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000312	0.00149	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SPHK1—malignant glioma	0.000309	0.00147	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ASMT—malignant glioma	0.000305	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP2C18—malignant glioma	0.000302	0.00144	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—PPARG—malignant glioma	0.000298	0.00142	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000292	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—H3F3A—malignant glioma	0.000292	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—BCHE—malignant glioma	0.000292	0.00139	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—SLC5A5—malignant glioma	0.000288	0.00137	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000288	0.00137	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—BCAN—malignant glioma	0.000287	0.00137	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000285	0.00136	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH3—malignant glioma	0.000274	0.00131	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000272	0.0013	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00027	0.00129	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00026	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000253	0.00121	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000251	0.0012	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00025	0.00119	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH2—malignant glioma	0.000246	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTT1—malignant glioma	0.000245	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000235	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GSTP1—malignant glioma	0.000232	0.00111	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—IDH2—malignant glioma	0.000231	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS1—malignant glioma	0.000229	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000228	0.00109	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CAT—malignant glioma	0.000226	0.00108	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000219	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2B6—malignant glioma	0.000217	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—NCOR1—malignant glioma	0.000213	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—BCHE—malignant glioma	0.000213	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—CDKN2B—malignant glioma	0.000211	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—SLC5A5—malignant glioma	0.00021	0.001	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000205	0.000977	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NCOR1—malignant glioma	0.0002	0.000956	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000199	0.00095	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—IDH1—malignant glioma	0.000199	0.000949	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000197	0.000941	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000194	0.000925	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SPHK1—malignant glioma	0.000192	0.000918	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000192	0.000915	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP2C18—malignant glioma	0.000188	0.000899	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CAV1—malignant glioma	0.000174	0.000829	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000172	0.000821	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—malignant glioma	0.00017	0.000811	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GSTP1—malignant glioma	0.00017	0.000809	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000166	0.000792	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CAT—malignant glioma	0.000165	0.000787	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CG—malignant glioma	0.000158	0.000755	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—NCOR1—malignant glioma	0.000156	0.000743	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PPARG—malignant glioma	0.000153	0.000729	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTT1—malignant glioma	0.000152	0.000727	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—NOTCH1—malignant glioma	0.000152	0.000726	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PPARG—malignant glioma	0.000144	0.000685	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000143	0.000685	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS1—malignant glioma	0.000143	0.000681	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000142	0.000677	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.00014	0.000668	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CD—malignant glioma	0.000139	0.000664	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—BCHE—malignant glioma	0.000133	0.000634	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—SLC5A5—malignant glioma	0.000131	0.000626	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CAV1—malignant glioma	0.000127	0.000606	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000121	0.000579	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CB—malignant glioma	0.000121	0.000579	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTGS2—malignant glioma	0.00012	0.000573	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CG—malignant glioma	0.000116	0.000552	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PPARG—malignant glioma	0.000112	0.000533	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GSTP1—malignant glioma	0.000106	0.000504	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PTEN—malignant glioma	0.000105	0.0005	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CAT—malignant glioma	0.000103	0.000491	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CD—malignant glioma	0.000102	0.000485	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—NCOR1—malignant glioma	9.71e-05	0.000463	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CB—malignant glioma	8.86e-05	0.000423	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTGS2—malignant glioma	8.78e-05	0.000419	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—COX8A—malignant glioma	8.24e-05	0.000393	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—malignant glioma	8.18e-05	0.000391	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CAV1—malignant glioma	7.91e-05	0.000378	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PTEN—malignant glioma	7.66e-05	0.000365	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PIK3CA—malignant glioma	7.39e-05	0.000353	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CG—malignant glioma	7.21e-05	0.000344	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ASMT—malignant glioma	7.01e-05	0.000334	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PPARG—malignant glioma	6.96e-05	0.000332	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BCAN—malignant glioma	6.59e-05	0.000314	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CD—malignant glioma	6.34e-05	0.000302	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—AKT1—malignant glioma	6.04e-05	0.000288	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—AKT1—malignant glioma	5.68e-05	0.000271	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CB—malignant glioma	5.52e-05	0.000264	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTGS2—malignant glioma	5.47e-05	0.000261	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PIK3CA—malignant glioma	5.4e-05	0.000258	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—IDH2—malignant glioma	5.31e-05	0.000253	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.99e-05	0.000238	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PTEN—malignant glioma	4.77e-05	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—IDH1—malignant glioma	4.57e-05	0.000218	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SPHK1—malignant glioma	4.42e-05	0.000211	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—AKT1—malignant glioma	4.41e-05	0.000211	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP2C18—malignant glioma	4.33e-05	0.000207	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTT1—malignant glioma	3.5e-05	0.000167	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PIK3CA—malignant glioma	3.37e-05	0.000161	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS1—malignant glioma	3.28e-05	0.000157	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—BCHE—malignant glioma	3.05e-05	0.000146	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—SLC5A5—malignant glioma	3.01e-05	0.000144	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—AKT1—malignant glioma	2.75e-05	0.000131	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GSTP1—malignant glioma	2.43e-05	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CAT—malignant glioma	2.36e-05	0.000113	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—NCOR1—malignant glioma	2.23e-05	0.000106	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CAV1—malignant glioma	1.82e-05	8.67e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.66e-05	7.9e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PPARG—malignant glioma	1.6e-05	7.62e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.46e-05	6.94e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.27e-05	6.05e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTGS2—malignant glioma	1.26e-05	6e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PTEN—malignant glioma	1.1e-05	5.23e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.73e-06	3.69e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—AKT1—malignant glioma	6.32e-06	3.01e-05	CbGpPWpGaD
